Background: Insulin resistance is considered to be the underlying pathophysiology of the obesityrelated cardiovascular risk factors in metabolic. The role of lipid lowering drugs in the treatment of insulin resistant states and metabolic syndrome is significant. Objective of the present study was to determine the effects of Simvastatin and L-carnitine, individually and in combination, on plasminogen activator inhibitor-1 levels as Cardiac Risk Factor in obese insulin-resistant Sprague-Dawley (SD) rats. Methods: Eighty healthy SD rats were divided into 5 groups of 16 rats each. Group-1 was given normal pellet diet and served as control while the rest were given high fat diet (HFD) to induce obesity. After two months of HFD, insulin resistance was confirmed and drug administration was carried out for one month in groups 3, 4 and 5 while group-2 served as control for them. At the end of this period, Plasminogen activator inhibitor-1 level was measured. Results: Plasminogen activator inhibitor-1 (PAI-1) levels were raised significantly in the group given HFD (11.78±3.58 ηg/ml from 2.66±1.80 ηg/ml in Group 1, ppp